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Abstract
We present a case of elective total knee arthroplasty where the surgical procedure was affected by the
neuromuscular blocking agent administered at induction of general anaesthesia. Recognition of this effect was vital
to avoid additional bone resection at the soft tissue balancing stage of the procedure.
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Case Report
A 59 year old male with a medical history of hypertension, non-
insulin dependent diabetes mellitus, angina and benign prostatic
hyperplasia whom underwent simultaneous bilateral primary total
knee arthroplasty surgery for osteoarthritis (Figure 1). The patient
received Atracurium 50 mg IV at the induction of general anaesthesia
for muscle relaxant purposes.
Figure 1: Patient’s left knee radiographs pre and immediately post
operation
Surgery on the first side was uneventful, with soft tissues balanced
using conventional techniques. Surgery to the second knee
commenced upon closure of the first knee. Soft tissue balancing of the
left knee initially seemed uneventful. A 10 mm trial spacer was used
for flexion and extension gap balancing and movements were normal.
During preparation of the tibia, it was then noticed that the trial
components became increasingly difficult to remove, and after removal
both flexion and extension gaps had decreased significantly. At 1 hour
and fifteen minutes post induction the knee gap had decreased such
that it was not possible to remove the trial polyethylene spacer from
the knee, the stage of the procedure was subsequently delayed.
Figure 2: The anaesthetic chart used during the case presented. A
further dose of atracurium is documented as given at 1345, 1 hour
and fifteen minutes after induction of anaesthesia
A further 25 mg IV bolus of Atracurium (Figure 2) was then given.
This enabled sufficient relaxation to enable soft tissue balancing to
continue without difficulty. A 10 mm trial spacer was then used to
check the gap and was put into the knee without problems encountered
beforehand. The operation was finished as planned with a cemented
total knee replacement and 10 mm polyethylene spacer (Figure 1).
EUA post wound closure, and clinical evaluation at clinic follow up
revealed good collateral stability both in flexion and extension.
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Discussion
Soft tissue management has a major influence on outcome in
primary total knee replacement [1]. It is therefore essential that
possible sources for error in soft tissue balancing are eliminated. We
report one such source of error, associated with the use of muscle
relaxant during anaesthesia.
At induction of anaesthesia, patients commonly receive a dose of
neuromuscular blocking drugs such as Atracurium, when having an
endotracheal tube placed for the general anaesthetic [2,3].
Neuromuscular blocking drugs such as atracurium block the
transmission through the neuromuscular junction at nicotinic
receptors and thus reduce skeletal muscle tone [2]. Non-depolarising
agents bind to receptors and prevent acetylcholine from stimulating
receptors. Their effect is to compete with acetylcholine for nicotinic
receptors. Their blockade is competitive and therefore gradual in onset
[2].
Neuromuscular blocking drugs administered to patients during the
induction of anaesthesia prior to arthroplasty surgery are detailed in
Table 1. A difference in their duration of action times is noted between
5 and 40 minutes depending on the dose given [2-6].
Muscle relaxant Dose (mg/kg) Duration of action (minutes)
Atracurium 0.3-0.6 20-40
Suxamethonium 1-2 5-10
Vecuronium 0.08-0.1 15-30
Rocuronium 0.6 30-40
Table 1: Duration of action of muscle relaxants [4,6-8]
Atracurium is a non-depolarising muscle relaxant. It is a short-
acting relaxant, which is rapidly broken down by the body. This makes
atracurium very predictable, as it wears off rapidly compared with the
longer-acting relaxants. A dose of 0.3-0.6 mg/kg will provide relaxation
for 20-40 minutes [3]. Depending on the nature of the surgery and the
physique of the patient, the return of muscle tone during surgery could
have an effect on soft tissue tension [3,7]. Therefore, the return of
muscle tone could theoretically affect the flexion and extension gap
during total knee replacement.
When considered in terms of timing during primary total
arthroplasty, and in particular simultaneous bilateral primary total
arthroplasty or complex primary total arthroplasty of the knee, the
upper limits of the duration of action are likely to coincide with the
soft tissue balancing of the knee.
As the effect of the muscle relaxants administered diminishes,
contraction of the knee may occur and significantly impede the soft
tissue balancing stage of the operation, in particular when balancing
the flexion and extension gaps. If this is not recognized it may lead to
an unnecessary recut of the femur or tibia. These may then create an
uneven soft tissue envelope around the implanted arthroplasty
components and alter the long term outcome of the primary
arthroplasty procedure [1,8].
Conclusion
The diminishing action of neuromuscular blockade may cause
contraction of the knee during arthroplasty, which if unrecognised can
lead to inappropriate bone resection. This should be understood by
both the surgeon and anaesthetist.
We suggest surgical teams should be aware of the use of
neuromuscular blocking agents administered during primary knee
arthroplasty operations and the timings of their duration of action as
this may coincide with crucial stages of the operation.
Likewise, anaesthetic teams should appreciate the importance of the
soft tissue balancing in the outcome of primary total arthroplasty and
should be prepared to adjust the timings or give further doses of
neuromuscular blocking agents accordingly.
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